Criteria to interpret cancer biomarker increments crossing the recommended cut-off compared in a simulation model focusing on false positive signals and tumour detection time-Reference-Cited by-同舟云学术

Criteria to interpret cancer biomarker increments crossing the recommended cut-off compared in a simulation model focusing on false positive signals and tumour detection time

Published:2014-04 Issue: Volume:431 Page:192-197
ISSN:0009-8981
Container-title:Clinica Chimica Acta
language:en
Short-container-title:Clinica Chimica Acta

Author:

Lund Flemming,Petersen Per Hyltoft,Pedersen Merete Frejstrup,Hassan Suher Othman Abu,Sölétormos György

Publisher

Elsevier BV

Subject

Biochemistry (medical),Clinical Biochemistry,Biochemistry,General Medicine

Reference15 articles.

1. Tumour markers cancer antigen 15.3, and tissue polypeptide antigen for monitoring metastatic breast cancer during first-line chemotherapy and follow-up;Sölétormos;Clin Chem,1996

2. Intensive post-operative follw-up of breast cancer patients with tumour markers: CEA, TPA or CA15.3 vs MCA and MCA-CA15.3 vs CEA-TPA-CA15.3 panel in the early detection of distant metastases;Nicolini;BMC Cancer,2006

3. Interpretation of results for tumour markers on the basis of analytical imprecision and biological variation;Sölétormos;Clin Chem,1993

4. Assessment of CA 15.3, CEA and TPA concentrations during monitoring of breast cancer;Sölétormos;Clin Chem Lab Med,2000

5. Progresssion criteria for cancer antigen 15.3 and carcinoembryonic antigen in metastatic breast cancer compared by computer simulation of marker data;Sölétormos;Clin Chem,2000

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Circulating Biomarkers in Oncology: Areas of Application, Critical Issues, and Perspectives;Clinical and Laboratory Medicine Textbook;2023

2. Modeling strategies to analyse longitudinal biomarker data: An illustration on predicting immunotherapy non-response in non-small cell lung cancer;Heliyon;2022-10

3. Toward a Framework for Outcome-Based Analytical Performance Specifications: A Methodology Review of Indirect Methods for Evaluating the Impact of Measurement Uncertainty on Clinical Outcomes;Clinical Chemistry;2019-11-01

4. Diagnostic validation and interpretation of longitudinal circulating biomarkers using a biomarker response characteristic plot;Clinica Chimica Acta;2018-12

5. Monitoring performance of progression assessment criteria for cancer antigen 125 among patients with ovarian cancer compared by computer simulation;Biomarkers in Medicine;2015-09